BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27838496)

  • 21. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ; Tian YM; Mole DR; Harris AL
    Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression via the AKT/mTOR-p70S6K signalling pathway in HeLa cells.
    Xie SR; Wang Y; Liu CW; Luo K; Cai YQ
    Phytother Res; 2012 Aug; 26(8):1133-41. PubMed ID: 22170854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noscapine inhibits hypoxia-mediated HIF-1alpha expression andangiogenesis in vitro: a novel function for an old drug.
    Newcomb EW; Lukyanov Y; Schnee T; Ali MA; Lan L; Zagzag D
    Int J Oncol; 2006 May; 28(5):1121-30. PubMed ID: 16596228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
    Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
    Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of NHE1 by small interfering RNA inhibits HIF-1α-induced angiogenesis in vitro via modulation of calpain activity.
    Mo XG; Chen QW; Li XS; Zheng MM; Ke DZ; Deng W; Li GQ; Jiang J; Wu ZQ; Wang L; Wang P; Yang Y; Cao GY
    Microvasc Res; 2011 Mar; 81(2):160-8. PubMed ID: 21185840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A feed-forward loop between nuclear translocation of CXCR4 and HIF-1α promotes renal cell carcinoma metastasis.
    Bao Y; Wang Z; Liu B; Lu X; Xiong Y; Shi J; Li P; Chen J; Zhang Z; Chen M; Wang L; Wu Z
    Oncogene; 2019 Feb; 38(6):881-895. PubMed ID: 30177838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of HIF-1alpha activity by BP-1 ameliorates adjuvant induced arthritis in rats.
    Shankar J; Thippegowda PB; Kanum SA
    Biochem Biophys Res Commun; 2009 Sep; 387(2):223-8. PubMed ID: 19664474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-Regulation of ENO1 by HIF-1α in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion.
    Zheng F; Jang WC; Fung FK; Lo AC; Wong IY
    PLoS One; 2016; 11(2):e0147961. PubMed ID: 26882120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current insights and future perspectives of hypoxia-inducible factor-targeted therapy in cancer.
    Ajith TA
    J Basic Clin Physiol Pharmacol; 2018 Dec; 30(1):11-18. PubMed ID: 30260792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of hypoxia inducible factor-1α downregulates the expression of epithelial to mesenchymal transition early marker proteins without undermining cell survival in hypoxic lens epithelial cells.
    Cammarata PR; Neelam S; Brooks MM
    Mol Vis; 2015; 21():1024-35. PubMed ID: 26392741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
    Zhu DM; Li DC; Zhang ZX; Zhang XY
    Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
    Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
    Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
    DeNiro M; Alsmadi O; Al-Mohanna F
    Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein α by hypoxia inducible factor-1α in bladder transitional carcinoma cells.
    Xue M; Li X; Chen W
    Mol Med Rep; 2015 Aug; 12(2):2121-7. PubMed ID: 25824695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma.
    Maroni P; Matteucci E; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA
    Breast Cancer Res Treat; 2011 Sep; 129(2):433-50. PubMed ID: 21069452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor.
    Sun L; Liu Y; Lin S; Shang J; Liu J; Li J; Yuan S; Zhang L
    Acta Oncol; 2013 May; 52(4):842-51. PubMed ID: 23409769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of Ca2+-independent phospholipase A2 in the translocation of hypoxia-inducible factor-1alpha to the nucleus under hypoxic conditions.
    Osada-Oka M; Takahashi M; Akiba S; Sato T
    Eur J Pharmacol; 2006 Nov; 549(1-3):58-62. PubMed ID: 16979159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.